FindTrial
Sign In

D000077203

3 trials

Sponsors

Kitahara Hideki, Obokata Masaru, TAKAMURA Toshinari

Conditions

Aortic stenosis Aortic Valve StenosesType2 diabetes patients with multiple atherosclerosis risk factors Type2 diabetesheart failure with preserved ejection fraction Heart failure with preserved ejection fraction, SGLT2 inhibitors, sarcopenia, nutrition

Phase 4

The efficacy of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients after transcatheter aortic valve implantation
RecruitingJPRN-jRCT1031250190
Kitahara HidekiAortic stenosis Aortic Valve Stenoses
Start: 2025-08-07Target: 100Updated: 2026-06-29

Unknown Phase

Pleiotropic Effects of Sodium glucose co-transporter 2 inhibitor on sympathetic nerve activity and organ network in patients with Type 2 diabetes
Active, not recruitingJPRN-jRCTs041200035
TAKAMURA ToshinariType2 diabetes patients with multiple atherosclerosis risk factors Type2 diabetes
Start: 2020-10-21Target: 40Updated: 2026-06-29
Preservation of Skeletal Muscle Mass with SGLT2 inhibitors under Nutritional Assessment and/or Intervention in Underweight HFpEF
RecruitingJPRN-jRCT1031250547
Obokata Masaruheart failure with preserved ejection fraction Heart failure with preserved ejection fraction, SGLT2 inhibitors, sarcopenia, nutrition
Start: 2025-12-04Target: 36Updated: 2026-06-29